Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemoporfin photodynamic therapy dose/exposure study for port-wine stain
ChiCTR-TRC-08000233Phase 2Completed
- Sponsor
- Peking University First Hospital
- Start
- Oct 2007
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hemoporfin in port-wine stain (3 arms), sponsored by Peking University First Hospital. Primary endpoints: Efficacy assessed by investigator evaluation, Efficacy assessed by subject evaluation and 1 more. Started Oct 2007; status: completed.
02
Drugs
hemoporfin
03
Conditions
port-wine stain
Beyond the preview
Go deeper on ChiCTR-TRC-08000233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000233.